| Dale Curtis Hogue |
Dale Curtis Hogue is the founder of Dune Lake Capital LLC. He is currently the Chief Executive Officer & Director at Alaunos Therapeutics, Inc. since 2024. In the past, Mr. Hogue worked as a Managing Director at Summer Street Research Partners in 2005, a Senior Research Analyst at DCF Capital LLC in 2003, and an Analyst at Discovery Capital Management LLC. Mr. Hogue's education includes an undergraduate degree from James Madison University in 1991, a graduate degree from The Johns Hopkins University in 1996, and an MBA from The Fuqua School of Business. |
| Holger Weis |
Holger Weis is the founder and currently holds the position of President & Principal at Weis Advisors, Inc., which was founded in 2018. He is also currently serving as Chairman at Alaunos Therapeutics, Inc. since 2020 and as an Independent Director at Jupiter Neurosciences, Inc. since 2021. In his former positions, Mr. Weis served as Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021, Senior Manager at Ernst & Young LLP from 1986 to 2000, Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005, President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017, Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010, and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011. Mr. Weis obtained his undergraduate degree from the University of Georgia in 1985. |
| Timothy M. Cunningham |
Timothy M. Cunningham was the founder and had founded Metatomix, Inc. in 2001, where he held the title of Chief Financial Officer from 2001 to 2010. He currently holds the position of Independent Director at ChitogenX, Inc. since 2021, Chief Financial Officer at Bionomics Ltd. since 2023, Chief Financial Officer at Alaunos Therapeutics, Inc. since 2021, Chief Financial Officer at Peak Bio, Inc. since 2022, Chief Financial Officer at Danforth Advisors LLC since 2020, and Chief Financial & Accounting Officer at Aileron Therapeutics, Inc. since 2024. Mr. Cunningham's former positions include Controller at Infinium Software, Inc., Chief Financial Officer & EVP-Administration at MediaBridge Technologies, Inc. from 1997 to 2000, Head-Audit & Comprehensive Services at PricewaterhouseCoopers LLP, Vice President-Finance & Operations at LogicNow SA from 2011 to 2014, Head-Audit at KPMG LLP, Chief Financial Officer & Senior Vice President at DialogTech, Inc. from 2014 to 2016, Chief Operating & Financial Officer at Wazoo Sports, Inc., Chief Financial Officer at Vestigo Ventures LLC, and Chief Financial Officer at Organogenesis Holdings, Inc. from 2016 to 2020. Mr. Cunningham's education includes an MBA from Boston University and an undergraduate degree from Boston College. |
| Robert Hofmeister |
Robert Hofmeister is an Independent Director at Alaunos Therapeutics, Inc. and a Co-Managing Director at Molkerei Hainichen Freiberg GmbH & Co. KG. He was previously the Global Head-Translational Immunotherapy at EMD Serono Research & Development Institute, Inc. from 2012 to 2015 and the Senior Vice President-Research & Development at TCR2 Therapeutics, Inc. from 2015 to 2022. He holds a doctorate degree from the University of Regensburg. |
| Robert W. Postma |
Robert W. Postma is the founder of Water Mill Asset Management Corp. He currently holds a position as an Independent Director at Alaunos Therapeutics, Inc. He completed his undergraduate degree at Lafayette College. |
| Jaime Ward Vieser |
Jaime Ward Vieser is the founder of Castle Hill Asset Management LLP and Castle Hill Asset Management LLC, both founded in 2009. At Castle Hill Asset Management LLP, he held the title of Chief Executive Officer from 2009 to 2012. At Castle Hill Asset Management LLC, he held the title of Chief Investment Officer from 2009 to 2016. Currently, Mr. Vieser is an Independent Director at Alaunos Therapeutics, Inc. since 2020 and a Manager at Brushwood LLC. He previously worked as a Portfolio Manager at Ignis Investment Services Ltd. from 2008 to 2009. Mr. Vieser received his undergraduate degree from the University of Michigan and his MBA from SMU-Cox School of Business. |
